Sally Rose Paredes
A5041674330- Lymphoma Diagnosis and Treatment
- T-cell and Retrovirus Studies
- Chronic Lymphocytic Leukemia Research
- Inflammatory Biomarkers in Disease Prognosis
- Viral-associated cancers and disorders
- Vector-Borne Animal Diseases
- CNS Lymphoma Diagnosis and Treatment
- COVID-19 and healthcare impacts
- Acute Lymphoblastic Leukemia research
- Animal Disease Management and Epidemiology
- Multiple and Secondary Primary Cancers
- Cancer, Lipids, and Metabolism
- Economic and Financial Impacts of Cancer
- Cancer Immunotherapy and Biomarkers
- Cutaneous lymphoproliferative disorders research
- Lung Cancer Treatments and Mutations
- Cancer Diagnosis and Treatment
- Circular RNAs in diseases
- Artificial Intelligence in Healthcare
- Head and Neck Cancer Studies
- Genetic factors in colorectal cancer
- Advanced Biosensing Techniques and Applications
- MRI in cancer diagnosis
- Vascular Tumors and Angiosarcomas
- Cancer survivorship and care
Hospital Nacional Cayetano Heredia
2016-2024
Universidad de San Martín de Porres
2020-2024
Martin University
2021
The University of Texas MD Anderson Cancer Center
2021
St Martins Hospital
2018-2020
Hospital Clínico Universitario Lozano Blesa
2013
Abstract Disease Overview Epstein Barr virus‐positive (EBV+) diffuse large B‐cell lymphoma (DLBCL), not otherwise specified (NOS) is an entity included in the 2016 WHO classification of lymphoid neoplasms. EBV+ DLBCL, NOS, aggressive associated with chronic EBV infection, and a poor prognosis standard chemotherapeutic approaches. Diagnosis The diagnosis made through careful pathological evaluation. Detection EBV‐encoded RNA (EBER) considered for diagnosis; however, clear cutoff positivity...
PURPOSE Adult T-cell leukemia/lymphoma (ATLL) is an aggressive disease caused by the human leukemia virus type 1. Real-world data of ATLL in Latin America are lacking. PATIENTS AND METHODS We analyzed patients with (acute, lymphomatous, chronic, and smoldering) encountered 11 American countries between 1995 2019. Treatment response was assessed according to 2009 consensus report. Survival curves were estimated using Kaplan-Meier method log-rank test. RESULTS identified 253 patients; 226...
En diciembre de 2019 se detectó por primera vez en China la existencia del SARS-CoV2, causante enfermedad COVID-19. El virus rápidamente propagó Europa y Asia, tardándose un par meses antes llegar a América Latina. Se ha demostrado que los pacientes desarrollan una severa tienen mayor riesgo mortalidad COVID-19 son aquellos con edades avanzadas presentan lo menos crónica, incluyendo el cáncer. Debido anterior, surgen muchas dudas grupo profesionales encargados brindar tratamiento cáncer...
Objective. Our aim was to evaluate whether NLR, LMR, and PLR serve as prognostic biomarkers in AM, the most frequent subtype of cutaneous melanoma (CM) Peru. Materials methods. A retrospective study conducted, including patients diagnosed with AM between 2010 2015. Survival analysis performed using Kaplan-Meier curves comparisons were made log-rank test. Univariate multivariate survival models constructed usingCox regression analysis. p-value less than 0.05 considered significant. Results....
e19072 Background: The lactate dehydrogenase/albumin ratio (RLA), a potentially promising inflammatory biomarker derived from the division of serum dehydrogenase and albumin values, has shown strong correlation with overall survival (OS) in patients diffuse large B-cell lymphoma (DLBCL). However, its validity our specific population requires confirmation. We aimed to validate RLA as an early predictor OS cohort Peruvian DLBCL. Methods: conducted retrospective study recruiting consecutive...
Readily accessible biomarkers for risk stratification in settings with limited resources are lacking. We evaluated the effect of high red distribution width-coefficient variation (RDW-CV) values (>14%) on all-cause and lymphoma-specific mortality outcomes among 118 patients peripheral T-cell lymphoma (PTCL) who received systemic treatment at two tertiary centers between 2010 2019. With a median follow-up 45 months, RDW-CV had lower 4-year overall survival rate (34% vs. 45%, p = 0.015) higher...